D
David Radley
Researcher at Merck & Co.
Publications - 5
Citations - 1437
David Radley is an academic researcher from Merck & Co.. The author has contributed to research in topics: Vaccination & Randomized controlled trial. The author has an hindex of 5, co-authored 5 publications receiving 1313 citations. Previous affiliations of David Radley include Université de Montréal.
Papers
More filters
Journal ArticleDOI
Efficacy of Quadrivalent HPV Vaccine against HPV Infection and Disease in Males
Anna R. Giuliano,Joel M. Palefsky,Stephen E. Goldstone,Edson D. Moreira,Mary E. Penny,Carlos Aranda,Eftyhia Vardas,Harald Moi,Heiko Jessen,Richard J. Hillman,Yen Hwa Chang,Daron G. Ferris,Danielle Rouleau,Janine T. Bryan,J. Brooke Marshall,Scott Vuocolo,Eliav Barr,David Radley,Richard M. Haupt,Dalya Guris +19 more
TL;DR: Quadrivalent HPV vaccine prevents infection with HPV-6, 11, 16, and 18 and the development of related external genital lesions in males 16 to 26 years of age.
Journal ArticleDOI
Safety and immunogenicity of a quadrivalent human papillomavirus (types 6, 11, 16, and 18) vaccine in HIV-infected children 7 to 12 years old.
Myron J. Levin,Anna-Barbara Moscicki,Lin-Ye Song,Terrence Fenton,William A. Meyer,Jennifer S. Read,Edward Handelsman,Barbara F. Nowak,Carlos Sattler,Alfred J. Saah,David Radley,Mark T. Esser,Adriana Weinberg +12 more
TL;DR: QHPV was safe and immunogenic in this cohort of HIV-infected children and Efficacy trials are warranted.
Journal ArticleDOI
Impact of baseline covariates on the immunogenicity of a quadrivalent (types 6, 11, 16, and 18) human papillomavirus virus-like-particle vaccine.
Anna R. Giuliano,Eduardo Lazcano-Ponce,Luisa L. Villa,Terry Nolan,Colin D. Marchant,David Radley,Greg Golm,Kathleen McCarroll,Jimmy Yu,Mark T. Esser,Scott Vuocolo,Eliav Barr +11 more
TL;DR: Age at vaccination initiation was inversely proportional to the vaccine-induced anti-HPV response, and data support vaccination with quadrivalent HPV vaccine across a broad range of baseline subject characteristics.
Journal ArticleDOI
Safety, tolerability, and immunogenicity of gardasil given concomitantly with Menactra and Adacel.
Keith S. Reisinger,Stan L. Block,Michelle Collins-Ogle,Colin D. Marchant,Melissa Catlett,David Radley,Heather L. Sings,Richard M. Haupt,Elizabeth I.O. Garner +8 more
TL;DR: Overall, concomitant administration of Gardasil administered concomitantly with Menactra and Adacel was generally well-tolerated and did not interfere with the immune response to the respective vaccines.
Journal ArticleDOI
Impact of an HPV6/11/16/18 L1 virus-like particle vaccine on progression to cervical intraepithelial neoplasia in seropositive women with HPV16/18 infection
Richard M. Haupt,Cosette M. Wheeler,Darron R. Brown,Suzanne M. Garland,Suzanne M. Garland,Daron G. Ferris,Jorma Paavonen,Matti Lehtinen,Marc Steben,Elmar A. Joura,Katherine E.D. Giacoletti,David Radley,Margaret James,Alfred J. Saah,Heather L. Sings +14 more
TL;DR: The data suggest HPV vaccination neither reduces nor enhances progression to HPV16/18‐related high grade cervical lesions, and cervical cytology screening and corresponding management should continue as per local recommendations.